The Newest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
Epidermal development issue receptor (EGFR) is a tyrosine kinase receptor concerned in homeostatic regulation of regular cells and carcinogenesis of epithelial malignancies. With speedy improvement of the precision drugs period, a collection of recent therapies concentrating on EGFR are underway.
- 4 EGFR monoclonal antibody medication (cetuximab, panitumumab, nimotuzumab, and necitumumab) are already on the market, and a dozen different EGFR monoclonal antibodies are in medical trials.
- Right here, we comprehensively evaluation the newly recognized organic properties and anti-tumor mechanisms of EGFR monoclonal antibodies.
- We summarize not too long ago accomplished and ongoing medical trials of the basic and new EGFR monoclonal antibodies.
- Extra importantly, in response to our new commonplace, we re-classify the advanced evolving tumor cell resistance mechanisms, together with these involving exosomes, non-coding RNA and the tumor microenvironment, in opposition to EGFR monoclonal antibodies.
- Lastly, we analyzed the constraints of EGFR monoclonal antibody remedy, and mentioned the present methods overcoming EGFR associated drug resistance.
- This evaluation will assist us higher perceive the most recent battles between EGFR monoclonal antibodies and resistant tumor cells, and the long run instructions to develop anti-tumor EGFR monoclonal antibodies with sturdy results.
A high-throughput neutralizing antibody assay for COVID-19 prognosis and vaccine analysis
Virus neutralization stays the gold commonplace for figuring out antibody efficacy. Subsequently, a high-throughput assay to measure SARS-CoV-2 neutralizing antibodies is urgently wanted for COVID-19 serodiagnosis, convalescent plasma remedy, and vaccine improvement.
Right here, we report on a fluorescence-based SARS-CoV-2 neutralization assay that detects SARS-CoV-2 neutralizing antibodies in COVID-19 affected person specimens and yields comparable outcomes to plaque discount neutralizing assay, the gold commonplace of serological testing.
The fluorescence-based neutralization assay is restricted to measure COVID-19 neutralizing antibodies with out cross reacting with affected person specimens with different viral, bacterial, or parasitic infections. Collectively, our method gives a speedy platform that may be scaled to display folks for antibody safety from COVID-19, a key parameter needed to securely reopen native communities.
controlpeptidecomprimary-antibodies
LEC Chemokine(LEC67) Antibody |
|||
| BNC800067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC810066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC810066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC810067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC810067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC940066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC940066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC940067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC940067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC880066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC880066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC880067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC880067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC430066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC430066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC430067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC430067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC400066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC400066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC400067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC400067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC050066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC050066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC050067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC050067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCAP0066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCAP0066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCAP0067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCAP0067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCB0066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCB0066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCB0067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Biotin conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCB0067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Biotin conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCR0066-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC66), RPE conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCR0067-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC67), RPE conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNUB0066-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNUB0066-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNUB0067-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNUB0067-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCP0066-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC66), PerCP conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCP0067-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against LEC Chemokine(LEC67), PerCP conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNUM0066-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against LEC Chemokine(LEC66), 1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNUM0067-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against LEC Chemokine(LEC67), 1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCH0066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNCH0066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCH0067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNCH0067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC040066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC040066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC040067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC040067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC550066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC550066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC550067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC550067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC610066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC610066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC610067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC610067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC680066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC680066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC680067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC680067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC470066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC470066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC470067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC470067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC700066-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC66) Antibody |
|||
| BNC700066-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC700067-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
|||
LEC Chemokine(LEC67) Antibody |
|||
| BNC700067-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
|||
LEC protein |
|||
| 30R-AL013 | Fitzgerald | 20 ug | EUR 327.6 |
|
Description: Purified recombinant Human LEC protein |
|||
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| 7-01792 | CHI Scientific | 5µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| 7-01793 | CHI Scientific | 20µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| 7-01794 | CHI Scientific | 1mg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
| HECCP-1601 | Cyagen | 5ug | Ask for price |
HCC-4, LEC, NCC-4, CCL16, human |
|||
| RC315-27 | Bio Basic | 5ug | EUR 125.26 |
CCL16 LEC/NCC-4 Human Recombinant Protein |
|||
| PROTO15467 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: CCL16 Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 97 amino acids and having a molecular mass of 11.2 kDa. ;The CCL16 is purified by proprietary chromatographic techniques. |
|||
LEC Recombinant Protein |
|||
| 40-396-0005mg | ProSci | 0.005 mg | EUR 311.1 |
|
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
|||
LEC Recombinant Protein |
|||
| 40-396-002mg | ProSci | 0.02 mg | EUR 437.1 |
|
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
|||
LEC Antibody / HCC-4 / CCL16 |
|||
| RQ4655 | NSJ Bioreagents | 100ug | EUR 356.15 |
|
Description: Chemokine (C-C motif) ligand 16 (CCL16) is a small cytokine belonging to the CC chemokine family that is known under several pseudonyms, including Liver-expressed chemokine (LEC) and Monotactin-1 (MTN-1). This gene is one of several cytokine genes clustered on the q-arm of chromosome 17. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for lymphocytes and monocytes but not for neutrophils. This cytokine also shows a potent myelosuppressive activity and suppresses proliferation of myeloid progenitor cells. The expression of this gene is upregulated by IL-10. |
|||
Drug Tolerant Anti-drug Antibody Assay for Infliximab Remedy in Medical Follow Identifies Constructive Instances Earlier
A subgroup of sufferers handled with infliximab lose response to the remedy and one purpose for that is the event of anti-drug antibodies (ADA). If used optimally, measuring drug and ADA degree might result in a extra customized and environment friendly remedy regime, and allow identification of ADA-positive sufferers earlier than the underlying illness flares or allergic reactions happen.
With the usage of a drug-tolerant ADA assay which might detect ADA no matter drug ranges within the pattern, we decided the affect of ADA on remedy failure to infliximab. The goals of this examine had been to estimate the real-life optimum serum infliximab (sIFX) degree and set a medical threshold worth for a drug-tolerant ADA assay. Trough ranges of sIFX had been measured with ELISA. Free ADA was measured with two drug-sensitive strategies (ELISA and a bioassay) and one drug-tolerant methodology (PandA).
Two real-life cohorts handled with infliximab had been included; a cross-sectional cohort together with sufferers with inflammatory rheumatic ailments (n = 270) and a potential cohort of rheumatoid arthritis (RA) sufferers (n = 73) adopted for 1 yr.
Regular vary of sIFX was estimated from the possible cohort and an arbitrary optimum drug degree was set to be between 1 and 6 μg/mL. Utilizing this vary, optimum sIFX was present in solely 60% (163/270) of the sufferers within the cross-sectional cohort. These sufferers had considerably higher remedy response than these with a drug degree below 1 μg/mL, who had an ADA frequency of 34% (19/56) utilizing the drug-tolerant methodology.
Within the potential cohort, the drug-tolerant assay might establish 34% (53/155 samples) as ADA optimistic in samples with sIFX degree >0.2 μg/mL. ADA had been seldom detected in sufferers with >1 μg/mL sIFX, with three fascinating exceptions. A clinically related ADA threshold was decided to be >three RECL as measured with the drug-tolerant assay. In a real-life setting, there was a considerable variety of sufferers with suboptimal drug ranges and a proportion of those had ADA.
Each too low and too excessive drug ranges correlated with worse illness, however for various causes. Including a drug-tolerant assay enabled detection of ADA earlier and no matter drug degree at time of sampling.
Human anti TNF Alpha autoantibody ELISA kit |
|||
| E01A2132-96 | BlueGene | 1 plate of 96 wells | EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Human anti TNF Alpha autoantibody in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Rabbit Anti-human Topoisomerase II alpha (TOP2 alpha) IgG, aff pure |
|||
| TOP2A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Canine Tumor Necrosis Factor alpha (TNF-a) ELISA Kit, 96 tests, Quantitative |
|||
| 10460 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Bovine Tumor necrosis factor alpha (TNF-A) ELISA Kit, 96 tests, Quantitative |
|||
| 9810 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Antibody for Human TNF alpha |
|||
| SPC-1315D | Stressmarq | 0.1ml | EUR 376.8 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is unconjugated. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-A390 | Stressmarq | 0.1ml | EUR 433.2 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to ATTO 390. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-A488 | Stressmarq | 0.1ml | EUR 432 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to ATTO 488. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-A565 | Stressmarq | 0.1ml | EUR 432 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to ATTO 565. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-A594 | Stressmarq | 0.1ml | EUR 432 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to ATTO 594. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-A633 | Stressmarq | 0.1ml | EUR 432 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to ATTO 633. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-A655 | Stressmarq | 0.1ml | EUR 432 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to ATTO 655. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-A680 | Stressmarq | 0.1ml | EUR 432 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to ATTO 680. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-A700 | Stressmarq | 0.1ml | EUR 432 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to ATTO 700. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-ALP | Stressmarq | 0.1ml | EUR 426 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to Alkaline Phosphatase. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-APC | Stressmarq | 0.1ml | EUR 430.8 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to APC . |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-APCCY7 | Stressmarq | 0.1ml | EUR 518.4 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to APC/Cy7. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-BI | Stressmarq | 0.1ml | EUR 428.4 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to Biotin. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-DY350 | Stressmarq | 0.1ml | EUR 523.2 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to Dylight 350. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-DY405 | Stressmarq | 0.1ml | EUR 494.4 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to Dylight 405. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-DY488 | Stressmarq | 0.1ml | EUR 471.6 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to Dylight 488. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-DY594 | Stressmarq | 0.1ml | EUR 476.4 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to Dylight 594. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-DY633 | Stressmarq | 0.1ml | EUR 464.4 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to Dylight 633. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-FITC | Stressmarq | 0.1ml | EUR 423.6 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to FITC. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-HRP | Stressmarq | 0.1ml | EUR 418.8 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to HRP. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-P594 | Stressmarq | 0.1ml | EUR 440.4 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to PE/ATTO 594. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-PCP | Stressmarq | 0.1ml | EUR 430.8 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to PerCP. |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-RPE | Stressmarq | 0.1ml | EUR 429.6 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to RPE . |
|||
Antibody for Human TNF alpha |
|||
| SPC-1315D-STR | Stressmarq | 0.1ml | EUR 430.8 |
|
Description: A polyclonal antibody for TNF alpha from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from internal of human TNFA.. The Antibody is tested and validated for IHC, ICC/IF, ELISA assays with the following recommended dilutions: IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This TNF alpha antibody is conjugated to Streptavidin. |
|||
Rabbit Anti-Human alpha-Tubulin IgG |
|||
| TUBA13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Recombinant (E.Coli) Human p38 alpha/SAPK2 alpha |
|||
| RP-675 | Alpha Diagnostics | 1 ug | EUR 343.2 |
Monoclonal Anti-Human Tumor Necrosis Factor-Alpha (TNF-alpha) IgG #1 aff. Pure |
|||
| TNFA11-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Monoclonal Anti-Human Tumor Necrosis Factor-Alpha (TNF-alpha) IgG #2, aff. Pure |
|||
| TNFA12-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Monoclonal Anti-Human alpha-Tubulin IgG |
|||
| TUBA12-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Rabbit Anti-Rat TNF-alpha Converting Enzyme (TACE) antiserum |
|||
| TACE11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Human TNF alpha Protein |
|||
| abx060828-005mg | Abbexa | 0.05 mg | EUR 661.2 |
Alpha 2-Antiplasmin, Human Plasma |
|||
| A2AP15-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Alpha 1-Antitrypsin, Human Plasma |
|||
| A1AT15-N | Alpha Diagnostics | 1 mg | EUR 196.8 |
Chicken Anti-Human alpha 1 anti-trypsin IgG/Y |
|||
| A1AT12-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Rabbit Anti-Human p73 alpha antiserum # 2 |
|||
| P73A12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Guinea pig Tumor Necrosis Factor Alpha (TNF-a) ELISA Kit, 96 tests, Quantitative |
|||
| 9870 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Tumor necrosis factor alpha TNF-? (72 - 82), human (AA: Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg) (MW: 1171.33) |
|||
| SP-86635-5 | Alpha Diagnostics | 5 mg | EUR 343.2 |
Rabbit Anti-Human Glutathione Transferase alpha (GST-alpha) antiserum |
|||
| GSTA12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Alpha 1-Antichymotrypsin , Human Plasma |
|||
| A1CT15-N-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Goat Anti-Human Tumor Necrosis Factor-Alpha (TNF-alpha) IgG #2, aff. Pure (neutralzing) |
|||
| TNFA13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Rabbit Anti-Human Estrogen receptor alpha (ER-alpha) peptide IgG |
|||
| ERA12-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human p73 alpha/beta antiserum # 1 |
|||
| P73A11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Monoclonal anti-human Alpha (FSH-Alpha), IgG clone 3 aff pure |
|||
| FSHA12-M | Alpha Diagnostics | 1 mg | EUR 578.4 |
Anti-mouse TNF alpha Antibody |
|||
| RP1000 | BosterBio | 100ug/vial | EUR 400.8 |
Goat Anti-Human Lutenizing Hormone Alpha (LH-Alpha) IgG aff pure |
|||
| LHA13-A | Alpha Diagnostics | 1 mg | EUR 343.2 |
human Topoisomerase II alpha (TOP2 alpha) Control/blocking peptide |
|||
| TOP2A11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Goat Anti-human Alpha fetoprotein (AFP) IgG, pure |
|||
| AFP13-A | Alpha Diagnostics | 1 mg | EUR 781.2 |
Human TNF alpha ELISA kit |
|||
| 55R-IB49623 | Fitzgerald | 96 wells | EUR 1413.6 |
|
Description: ELISA kit for the detection of TNF alpha in the research laboratory |
|||
Human TNF alpha ELISA kit |
|||
| 55R-1690 | Fitzgerald | 1 kit | EUR 481.2 |
|
Description: ELISA kit for the detection of TNF alpha in the research laboratory |
|||
Goat Anti-human Chorionic Gonadotropin Alpha (hCG-Alpha) IgG aff pure |
|||
| HCGA13-A | Alpha Diagnostics | 1 mg | EUR 343.2 |
Rabbit Anti-Human p73 alpha/ IgG # 2, aff pure |
|||
| P73A12-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human HE2 alpha IgG #1, aff pure |
|||
| HE2A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Human TNF Alpha (TNFA) Protein |
|||
| 20-abx670178 | Abbexa |
|
|
Recombinant (E.Coli) purified human Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
|||
| TNFA15-R-10 | Alpha Diagnostics | 10 ug | EUR 270 |
Recombinant purified, human Interleukin-1 alpha (IL-1 alpha), active |
|||
| IL1A15-R-10 | Alpha Diagnostics | 10 ug | EUR 416.4 |
Rabbit Anti-Human alpha-Tubulin IgG-HRP Conjugate |
|||
| TUBA13-HRP | Alpha Diagnostics | 100 ul | EUR 518.4 |
Recombinant Human Alpha-Synuclein |
|||
| RP-847 | Alpha Diagnostics | 20 ug | EUR 196.8 |
Tumor necrosis factor alpha TNF-? (78-96) (human) (AA: His-Thr-Ile-Ser-Arg-Ile-Ala-Val-Ser-Tyr-Gln-Thr-Lys-Val-Asn-Leu-Leu-Ser-Ala) (MW: 2101.45) |
|||
| SP-89730-1 | Alpha Diagnostics | 1 mg | EUR 196.8 |
Goat Anti-Ferret IgA (alpha), unlabeled |
|||
| 70519 | Alpha Diagnostics | 0.5 mg | EUR 255.6 |
Rabbit Anti-Human alpha-Tubulin IgG-Biotin Conjugate |
|||
| TUBA13-BTN | Alpha Diagnostics | 100 ul | EUR 562.8 |
Human Alpha-Thrombin (human plasma), purified |
|||
| TBNA16-N-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Tumor necrosis factor alpha TNF-? (46-65) (human) (AA: Asn-Gln-Leu-Val-Val-Pro-Ser-Glu-Gly-Leu-Tyr-Leu-Ile-Tyr-Ser-Gln-Val-Leu-Phe-Lys) (MW: 2310.74) |
|||
| SP-89728-1 | Alpha Diagnostics | 1 mg | EUR 489.6 |
Rabbit Anti-Rat TNF-alpha Converting Enzyme (TACE), IgG aff. Pure |
|||
| TACE11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human Resistin-Like protein alpha (RELM-alpha/FIZZ1) antiserum #2 |
|||
| RELMA12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Goat Anti-Human Alpha 1-Antitrypsin (A1AT) IgG, unlabeled |
|||
| A1AT11-A | Alpha Diagnostics | 100 ul | EUR 489.6 |
Chicken Anti-Human Alpha 2 Macroglobulin (A2M) IgG/Y |
|||
| A2MG13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Rabbit Anti-Rat Glutathione Transferase alpha (GST-alpha) antiserum |
|||
| GSTA11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
TNF alpha |
|||
| GT15064 | Neuromics | 100 ug | EUR 631.2 |
TNF alpha |
|||
| GT15113 | Neuromics | 100 ug | EUR 631.2 |
Rabbit Anti-Human p73 alpha/beta IgG # 1, aff pure |
|||
| P73A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Tumor necrosis factor alpha TNF-? (31 - 45), human (AA: Arg-Arg-Ala-Asn-Ala-Leu-Leu-Ala-Asn-Gly-Val-Glu-Leu-Arg-Asp) (MW: 1667.90) |
|||
| SP-86636-1 | Alpha Diagnostics | 1 mg | EUR 196.8 |
anti-TNF alpha |
|||
| YF-PA24865 | Abfrontier | 50 ul | EUR 400.8 |
|
Description: Mouse polyclonal to TNF alpha |
|||
Monoclonal Anti-Human Chorionic Gonadotropin Alpha (hCG-alpha) IgG #1, aff pure |
|||
| HCGA11-M | Alpha Diagnostics | 1 mg | EUR 343.2 |
TNF alpha antibody |
|||
| 10-T60A | Fitzgerald | 1 mg | EUR 159.6 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10-T60B | Fitzgerald | 1 mg | EUR 536.4 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10-T60C | Fitzgerald | 1 mg | EUR 536.4 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10-T60D | Fitzgerald | 1 mg | EUR 522 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-10252 | Fitzgerald | 50 ul | EUR 262.8 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-2119 | Fitzgerald | 100 ul | EUR 457.2 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-2976 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-2986 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-3098 | Fitzgerald | 100 ug | EUR 488.4 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-3099 | Fitzgerald | 100 ug | EUR 488.4 |
|
Description: Mouse monoclonal HBxAg antibody |
|||
TNF alpha antibody |
|||
| 10R-6647 | Fitzgerald | 50 ug | EUR 184.8 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-6648 | Fitzgerald | 50 ug | EUR 184.8 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-6649 | Fitzgerald | 50 ug | EUR 184.8 |
|
Description: Armenian Hamster monoclonal TNF alpha antibody |
|||
TNF alpha antibody |
|||
| 10R-7734 | Fitzgerald | 500 ug | EUR 678 |
|
Description: Mouse monoclonal TNF alpha antibody |
|||